No Data
No Data
Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW), Context Therapeutics (CNTX) and Xenetic Biosciences (XBIO)
Context Therapeutics Secures Funding for Cancer Therapy Pipeline
Express News | Context Therapeutics Enters $75M At-The-Market Offering Agreement, Allocating Proceeds To R&D, Working Capital, And Potential Asset Acquisitions
Express News | Context Therapeutics Inc - Under Sales Agreement, May Offer & Sell up to $75 Million in Common Stock
Express News | Context Therapeutics Inc - Enters Sales Agreement With Leerink Partners
D. Boral Capital Initiates Coverage On Context Therapeutics With Buy Rating, Announces Price Target of $9